The Valley Desk

NCT05070247 · Interventional trial

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Breast Cancer, Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Kidney Cancer, Mesothelioma, Nasopharyngeal Cancer, Non-small Cell Lung Cancer (NSCLC), Non-squamous, Pancreatic Cancer, Squamous Cell Cancer of Head and Neck (SCCHN)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov